Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
NCT Number: NCT02376504
The primary objective of this project is to determine the effects of decreasing sedentary behavior at work by at least 3hrs/day using treadmill (walking and standing) and sit-to-stand (standing only) workstations on the health of overweight office workers.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02114, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
This is a 12-month, cluster-randomized trial with an intent-to-treat design to determine the effects of using treadmill and sit-to-stand workstations at the workplace on health variables in overweight office workers (N=66) with seated desk jobs and (2) to compare the efficacies of treadmill and sit-to-stand workstations in decreasing workplace sedentary behavior. The intervention will examine the effects of using these workstations on weight, cardiovascular and metabolic health variables , musculoskeletal discomfort, psychological affect and job stress. The study will also measure change in time spent sitting, standing and walking will be measured using wearable non-invasive acceleration sensors.
Time frame: Baseline, 3, 6, 12 months
Northeastern University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02932787
Workplace Inactivity
View Trial DetailsNCT05753358
Behavior, Cardiovascular Diseases
Portland, Oregon, United States
View Trial Details